 Recombinant Fusion Proteins
"Recombinant Fusion Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes.
| Descriptor ID |
D011993
|
| MeSH Number(s) |
D12.776.828.300
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Fusion Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Fusion Proteins".
This graph shows the total number of publications written about "Recombinant Fusion Proteins" by people in this website by year, and whether "Recombinant Fusion Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 2 | 7 | 9 | | 1993 | 3 | 6 | 9 | | 1994 | 0 | 13 | 13 | | 1995 | 0 | 12 | 12 | | 1996 | 4 | 13 | 17 | | 1997 | 3 | 10 | 13 | | 1998 | 1 | 12 | 13 | | 1999 | 1 | 8 | 9 | | 2000 | 1 | 15 | 16 | | 2001 | 2 | 21 | 23 | | 2002 | 0 | 26 | 26 | | 2003 | 3 | 9 | 12 | | 2004 | 2 | 15 | 17 | | 2005 | 3 | 8 | 11 | | 2006 | 1 | 14 | 15 | | 2007 | 1 | 9 | 10 | | 2008 | 3 | 12 | 15 | | 2009 | 5 | 3 | 8 | | 2010 | 5 | 20 | 25 | | 2011 | 4 | 11 | 15 | | 2012 | 3 | 10 | 13 | | 2013 | 8 | 7 | 15 | | 2014 | 6 | 4 | 10 | | 2015 | 7 | 8 | 15 | | 2016 | 4 | 11 | 15 | | 2017 | 4 | 5 | 9 | | 2018 | 1 | 4 | 5 | | 2019 | 2 | 1 | 3 | | 2020 | 2 | 5 | 7 | | 2021 | 4 | 4 | 8 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Recombinant Fusion Proteins" by people in Profiles.
-
Jones AA, Morgenstern JL, Mandair D, Pedler MG, Olson JL. EFFICACY OF INTRAVITREAL AFLIBERCEPT INJECTIONS IN THE TREATMENT OF IDIOPATHIC RETINAL VASCULITIS, ANEURYSMS, AND NEURORETINITIS SYNDROME. Retin Cases Brief Rep. 2022 Jul 01; 16(4):515-519.
-
Wang X, Hu C, Ye W, Wang J, Dong X, Xu J, Li X, Zhang M, Lu H, Zhang F, Wu W, Dai S, Wang HW, Chen Z. Structure of Rift Valley Fever Virus RNA-Dependent RNA Polymerase. J Virol. 2022 02 09; 96(3):e0171321.
-
Roy S, Curry SD, Bibbey MG, Chapnick DA, Liu X, Goodwin AP, Cha JN. Effect of covalent photoconjugation of affibodies to epidermal growth factor receptor (EGFR) on cellular quiescence. Biotechnol Bioeng. 2022 01; 119(1):187-198.
-
Cantrell MS, Wall JD, Pu X, Turner M, Woodbury L, Fujise K, McDougal OM, Warner LR. Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies. Protein Expr Purif. 2022 01; 189:105989.
-
Takeda K, Kim SH, Joetham A, Petrache I, Gelfand EW. Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema. Respir Res. 2021 Jul 16; 22(1):207.
-
Lénon M, Ke N, Ren G, Meuser ME, Loll PJ, Riggs P, Berkmen M. A useful epitope tag derived from maltose binding protein. Protein Sci. 2021 06; 30(6):1235-1246.
-
Rogawski DS, Deng J, Li H, Miao H, Borkin D, Purohit T, Song J, Chase J, Li S, Ndoj J, Klossowski S, Kim E, Mao F, Zhou B, Ropa J, Krotoska MZ, Jin Z, Ernst P, Feng X, Huang G, Nishioka K, Kelly S, He M, Wen B, Sun D, Muntean A, Dou Y, Maillard I, Cierpicki T, Grembecka J. Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity. Nat Commun. 2021 05 14; 12(1):2792.
-
Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman A, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, Barnes J, Linde PG, de Oliveira Pena J, Badesch DB. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2021 04 01; 384(13):1204-1215.
-
Christakopoulos GE, DeFor TE, Hage S, Wagner JE, Linden MA, Brunstein C, Bejanyan N, Verneris MR, Smith AR. Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation. Transplant Cell Ther. 2021 06; 27(6):497.e1-497.e6.
-
Ribeiro ÁL, Araújo FP, Martins JP, Lourenço AA, Huang J, Pereira FV, Andrade LAF, Paim AAO, da Fonseca FG, Barbosa-Stancioli EF, Martins-Filho OA, Peruhype-Magalhães V, Tsuji M, Coelho-Dos-Reis JG. A chimeric HLA-A2:ß2M:Ig fusion protein for the study of virus-specific CD8+ T-cells. J Immunol Methods. 2021 05; 492:112997.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|